News
MyChesCo on MSN56m
ArriVent BioPharma Posts Q2 Loss as Cancer Drug Pipeline Advances Toward Key Milestones
ArriVent BioPharma, Inc. (Nasdaq: AVBP) reported a wider second-quarter loss as the company pressed forward with late-stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback